A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.
Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.
Why choose Orlando for clinical trials?
Orlando offers a vast array of advantages for individuals considering participation in clinical trials. The city is home to a diverse population, which helps create a wide range of participants, enhancing the reliability and applicability of research findings.
Additionally, Orlando’s thriving healthcare ecosystem fosters an environment of innovation and collaboration, with a strong emphasis on advancing medical research and treatment. By participating in a clinical trial in Orlando, participants not only gain access to innovative therapies but also play a crucial role in advancing scientific knowledge.
Common conditions studied in Orlando
In Orlando, clinical trials focus on a variety of medical conditions, reflecting the region's strengths in healthcare and research.
Cardiovascular Diseases
Given Florida's demographic profile, which includes a large population of older adults, cardiovascular health is a major priority for Orlando-based researchers. Clinical trials in Orlando explore new medications, surgical techniques, and lifestyle interventions aimed at treating conditions such as coronary artery disease, arrhythmias, and heart failure.
Researchers here often collaborate with leading cardiology centers to ensure that findings can translate into effective treatments for patients both in the local region and farther afield.
Neurological disorders
With an aging population, research into neurological disorders such as Alzheimer’s and Parkinson’s disease is particularly pertinent. Neurology clinical trials investigate new drug therapies, cognitive interventions, and lifestyle changes that may slow disease progression or improve quality of life. Collaboration with local universities and research institutes supports these efforts, fostering a comprehensive approach to neurological health.
Cancer
Orlando has emerged as a hub for oncology research, with multiple institutions conducting trials on cutting-edge therapies for various cancers. Studies often focus on personalized medicine, immunotherapy, and novel drug combinations targeting breast, lung, prostate, and colorectal cancers. The goal is to enhance survival rates and reduce side effects through innovative treatment protocols.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Diabetes and Metabolic Disorders
The high rate of diabetes in Florida has led to significant research efforts focused on both Type 1 and Type 2 diabetes. Clinical trials for diabetes in Orlando assess new pharmacological treatments, insulin delivery systems, and behavioral interventions aimed at improving blood sugar control and reducing complications. The state's unique climate also provides opportunities for studying the effects of environmental factors on metabolic health.
Mental health conditions
As awareness of mental health grows, so too does the research dedicated to understanding these conditions. Clinical trials focused on mental health often target conditions such as depression, anxiety, PTSD, and bipolar disorder, exploring new therapeutic approaches including pharmacological treatments, psychotherapy, and innovative technology-based interventions. Partnerships with local mental health organizations help facilitate access to participants and ensure culturally sensitive approaches.
Chronic pain and musculoskeletal disorders
Chronic pain is a widespread issue in Orlando, leading to extensive research in this field. Clinical trials investigate new pain management techniques, rehabilitation strategies, and treatments for conditions like arthritis and fibromyalgia. The focus is on enhancing patient outcomes through evidence-based practices and innovative therapies that can provide relief and improve functionality.
Local regulations and guidelines
In Orlando, clinical trials are governed by a framework of regulations designed to ensure participant safety and data integrity. The Food and Drug Administration (FDA) oversees clinical trials nationally, requiring adherence to Good Clinical Practice (GCP) guidelines, which encompass ethical considerations, informed consent processes, and rigorous reporting standards.
Additionally, local Institutional Review Boards (IRBs) review and approve study protocols to protect the rights and welfare of participants, ensuring all research aligns with ethical standards and regulatory requirements.
Florida state laws also impose specific guidelines on clinical research, emphasizing the importance of transparency and accountability. Researchers must register their trials and comply with state regulations regarding the management of clinical data, participant recruitment, and adverse event reporting.
Benefits of participating in clinical trials
Volunteering in a clinical trial offers a unique chance to experience innovative treatments and therapies prior to their widespread availability. Participants receive tailored care from leading healthcare professionals who provide extensive monitoring and personalized support throughout the research process.
Participation in clinical trials is essential for advancing medical research and can result in transformative breakthroughs in the treatment and prevention of numerous health conditions. By enrolling, individuals not only gain early access to novel medical interventions but also significantly contribute to the body of scientific knowledge. This involvement plays a vital role in shaping future healthcare practices, ultimately enhancing patient outcomes and expanding treatment options for others down the line.
How to enroll in a clinical trial in Orlando
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.